Trials / Completed
CompletedNCT00998998
The Anemia Control Program: Early Intervention
Iron Deficiency Anemia and Infant Behavior: Early Intervention Study II
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 277 (actual)
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NIH
- Sex
- All
- Age
- 6 Months – 12 Months
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to determine if a home-based intervention to foster child development improved behavior and development in infants with IDA.
Detailed description
Iron-deficiency anemia (IDA) is associated with alterations in infant behavior and development that may not correct with iron therapy. The purpose of this study was to determine if a home-based intervention to foster child development improved behavior and development in infants with IDA. IDA and non-anemic infants were randomly assigned to a year of intervention or surveillance only. Infants were enrolled and began study participation at 6 or 12 months. All infants were treated with oral iron and visited weekly to record iron intake, feeding, and health (surveillance). For infants randomized to intervention, the weekly home visit included an hour-long program fostering child development by supporting the mother-infant relationship. Psychologists, unaware of iron status or intervention assignment, assessed cognitive, motor, and social-emotional development (Bayley Scales) at the beginning, midpoint, and end of the year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Home stimulation | Weekly visit of one hour to the home over the course of one year to foster the mother-child relationship. |
| BEHAVIORAL | Surveillance | Weekly visits to the home over the course of one year to record iron intake, feeding, and health information. |
| DIETARY_SUPPLEMENT | Iron | Six-month-old infants treated orally for 1 y with 15 mg elemental Fe/d as ferrous sulfate. Twelve-month old infants treated orally for a minimum of 6 months with 30 mg elemental Fe/d. |
Timeline
- Start date
- 1992-04-01
- Primary completion
- 1996-07-01
- Completion
- 1996-07-01
- First posted
- 2009-10-21
- Last updated
- 2010-07-21
Locations
1 site across 1 country: Chile
Source: ClinicalTrials.gov record NCT00998998. Inclusion in this directory is not an endorsement.